It's early days for xenotransplantation, but eGenesis, Eledon, United Therapeutics and more are working to develop solutions ...

Dr. Shivaani Kummar is stepping into the role of OHSU Knight Cancer Institute chief executive on an interim basis, OHSU ...

Jeffrey Graves; President, Chief Executive Officer, Director; 3D Systems Corp Jeffrey Creech; Chief Financial Officer, Executive Vice President; 3D Systems Corp Greetings, and welcome to the 3D ...

Augustine Therapeutics raises oversubscribed EUR 78 million / USD 85 million Series A financing round Novo Holdings and Jeito Capital co-led the deal, supported by Asabys Partners and existing investo ...

said Samira Sakhia, President and CEO of Knight. Minjuvi ® (tafasitamab ... Knight's Latin American subsidiaries operate under United Medical, Biotoscana Farma and Laboratorio LKM. Knight Therapeutics ...

A kickoff meeting was recently held in March in the United States ... dermatitis market," said Janice Marie McCourt, CEO of Hudson Therapeutics. "We have strong interest from numerous specialty ...

and I believe this transaction will maximize value for our stockholders and provide accelerated access to Unloxcyt in the United States, Europe, and other markets worldwide." 1. Sun Pharma to Acquire ...

President & CEO of Arcturus Therapeutics. "Arcturus continues to make excellent progress with our STARR® sa-mRNA vaccines pipeline and platform. We are very pleased to have recently received ...

Evofem will maintain ownership of the asset and continue to commercialize PHEXXI in the United States and internationally ... U.S.,” said Saundra Pelletier, CEO of Evofem.

EQS-News: Newron Pharmaceuticals S.p.A. / Key word (s): Annual Report Newron presents 2024 financial results and provides 2025 outlook 01.04.2025 / 07:00 CET/CEST The issuer is solely responsible ...